Intravenous iron [25]

New England Journal of Medicine

Volumn 357, Issue 1, 2007, Pages 93-94

  Auerbach, Michael ^a   Rodgers, George M ^b  

^a Auerbach Hematology and Oncology   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; FERRIC GLUCONATE; FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; IRON; IRON DEXTRAN; FERRIC ION; FERRIC OXIDE, SACCHARATED; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANEMIA; CLINICAL MEDICINE; FOOD AND DRUG ADMINISTRATION; HEMATOLOGY; HEMODIALYSIS; HOSPITAL; HUMAN; LETTER; MARKET; NEPHROLOGIST; NEPHROLOGY; ONCOLOGY; PHYSICIAN; PRIORITY JOURNAL; CHEMISTRY; DRUG APPROVAL; INTRAVENOUS DRUG ADMINISTRATION; MOLECULAR WEIGHT; RENAL REPLACEMENT THERAPY; UNITED STATES;

ANEMIA; DRUG APPROVAL; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; IRON-DEXTRAN COMPLEX; MOLECULAR WEIGHT; RENAL DIALYSIS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 34347381712     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc070203     Document Type: Letter

References (5)

1. Adamson JW, Eschbach JW. Erythropoietin for end-stage renal disease. N Engl J Med 1998;339:625-7.
2. Coyne DW, Adkinson NF, Nissenson AR, et al. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int 2003;63:217-24.
3. Chertow GM, Mason PD, Vaage-Nilsen O, Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006;21:378-82.
4. Mamula P, Piccoli DA, Peck SN, Markowitz JE, Baldassano RN. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002;34:286-90.
5. Auerbach M, Ballard H, Trout JR, et al. Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial. J Clin Oncol 2004;22:1301-7.